Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Malaria

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 82 articles:
HTML format



Single Articles


    December 2021
  1. VAN DER PLUIJM RW, Phyo AP, Lek D, White NJ, et al
    Triple artemisinin-based combination therapies for malaria: proceed with caution - Authors' reply.
    Lancet. 2021;396:1976-1977.
    PubMed    


  2. WANG J, Xu C, Wong YK, Ma N, et al
    Triple artemisinin-based combination therapies for malaria: proceed with caution.
    Lancet. 2021;396:1976.
    PubMed    


    May 2021
  3. MOORTHY V, Binka F
    R21/Matrix-M: a second malaria vaccine?
    Lancet. 2021 May 5. pii: S0140-6736(21)01065.
    PubMed    


  4. DATOO MS, Natama MH, Some A, Traore O, et al
    Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial.
    Lancet. 2021 May 5. pii: S0140-6736(21)00943.
    PubMed     Abstract available


    April 2021
  5. LANE R
    Faith Osier: inspirational immunologist.
    Lancet. 2021;397:1533.
    PubMed    


    February 2021
  6. BATH D, Cook J, Govere J, Mathebula P, et al
    Effectiveness and cost-effectiveness of reactive, targeted indoor residual spraying for malaria control in low-transmission settings: a cluster-randomised, non-inferiority trial in South Africa.
    Lancet. 2021;397:816-827.
    PubMed     Abstract available


  7. STERNBERG ED, Cook J, Alou LPA, Assi SB, et al
    Impact and cost-effectiveness of a lethal house lure against malaria transmission in central Cote d'Ivoire: a two-arm, cluster-randomised controlled trial.
    Lancet. 2021;397:805-815.
    PubMed     Abstract available


  8. HSIANG MS, Mumbengegwi D, Chimumbwa J
    Mini-outbreak response for malaria using indoor residual spraying.
    Lancet. 2021;397:771-773.
    PubMed    


  9. CHANDA E
    Averting malaria transmission with lethal house lure intervention.
    Lancet. 2021;397:769-771.
    PubMed    


    December 2020

  10. Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa: an observational study.
    Lancet. 2020;396:1829-1840.
    PubMed     Abstract available


  11. ASHLEY EA, Yeka A
    Seasonal malaria chemoprevention: closing the know-do gap.
    Lancet. 2020;396:1778-1779.
    PubMed    


    November 2020
  12. MAKONI M
    Violence leads to health emergencies in Mozambique.
    Lancet. 2020;396:1621.
    PubMed    


    June 2020
  13. PRICE RN, Taylor WRJ, Thriemer K, White NJ, et al
    Primaquine for Plasmodium vivax malaria treatment - Authors' reply.
    Lancet. 2020;395:1972.
    PubMed    


  14. KARUNAJEEWA H, James R
    Primaquine for Plasmodium vivax malaria treatment.
    Lancet. 2020;395:1971-1972.
    PubMed    


    April 2020
  15. CHEN I, Dondorp A, Gosling R, Harvard K, et al
    Malaria eradication - Authors' reply.
    Lancet. 2020;395:e73.
    PubMed    


  16. ECKL J
    Malaria eradication.
    Lancet. 2020;395:e72.
    PubMed    


  17. MOLYNEUX D
    Malaria eradication.
    Lancet. 2020;395:e71.
    PubMed    


  18. KENNEDY J, McCoy D
    Malaria eradication.
    Lancet. 2020;395:e70.
    PubMed    


  19. WANG J, Xu C, Wong YK, Liao FL, et al
    Malaria eradication.
    Lancet. 2020;395:e69.
    PubMed    


  20. MULLER O, Lu G, Jahn A, Razum O, et al
    Malaria eradication.
    Lancet. 2020;395:e68.
    PubMed    


  21. ANTIPORTA DA, Rosas-Aguirre A, Chang J, Llanos-Cuentas A, et al
    Malaria eradication.
    Lancet. 2020;395:e67.
    PubMed    


  22. HSIANG MS, Ntuku H, Roberts KW, Dufour MK, et al
    Effectiveness of reactive focal mass drug administration and reactive focal vector control to reduce malaria transmission in the low malaria-endemic setting of Namibia: a cluster-randomised controlled, open-label, two-by-two factorial design trial.
    Lancet. 2020;395:1361-1373.
    PubMed     Abstract available


  23. KEATING C
    The history of the RTS,S/AS01 malaria vaccine trial.
    Lancet. 2020;395:1336-1337.
    PubMed    


  24. HETZEL MW, Chitnis N
    Reducing malaria transmission with reactive focal interventions.
    Lancet. 2020;395:1317-1319.
    PubMed    



  25. Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance for health: progress towards Sustainable Development Goal 3.
    Lancet. 2020 Apr 23. pii: S0140-6736(20)30608.
    PubMed     Abstract available


  26. SUNDEWALL J, Forsberg BC
    Understanding health spending for SDG 3.
    Lancet. 2020 Apr 23. pii: S0140-6736(20)30963.
    PubMed    


  27. STAEDKE SG, Gonahasa S, Dorsey G, Kamya MR, et al
    Effect of long-lasting insecticidal nets with and without piperonyl butoxide on malaria indicators in Uganda (LLINEUP): a pragmatic, cluster-randomised trial embedded in a national LLIN distribution campaign.
    Lancet. 2020;395:1292-1303.
    PubMed     Abstract available


  28. BAJUNIRWE F
    Pyrethroid resistance in sub-Saharan Africa.
    Lancet. 2020;395:1236-1237.
    PubMed    


  29. KILLEEN GF
    Control of malaria vectors and management of insecticide resistance through universal coverage with next-generation insecticide-treated nets.
    Lancet. 2020 Apr 15. pii: S0140-6736(20)30745.
    PubMed    


    March 2020
  30. WANG J, Xu C, Wong YK, He Y, et al
    Preparedness is essential for malaria-endemic regions during the COVID-19 pandemic.
    Lancet. 2020 Mar 16. pii: S0140-6736(20)30561.
    PubMed    


  31. VAN DER PLUIJM RW, Tripura R, Hoglund RM, Pyae Phyo A, et al
    Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial.
    Lancet. 2020 Mar 11. pii: S0140-6736(20)30552.
    PubMed     Abstract available


  32. ROSENTHAL PJ
    Are three drugs for malaria better than two?
    Lancet. 2020 Mar 11. pii: S0140-6736(20)30560.
    PubMed    


  33. MCGREADY R, Nosten F, Barnes KI, Mokuolu O, et al
    Why is WHO failing women with falciparum malaria in the first trimester of pregnancy?
    Lancet. 2020;395:779.
    PubMed    


    January 2020
  34. FOWKES FJI, Davidson E, Moore KA, McGready R, et al
    The invisible burden of malaria-attributable stillbirths.
    Lancet. 2020;395:268.
    PubMed    


  35. GETHING P, Hay S, Weiss D
    The invisible burden of malaria-attributable stillbirths - Authors' reply.
    Lancet. 2020;395:268-269.
    PubMed    


    October 2019
  36. TCHIOMBIANO S, Delfraissy JF, Dabis F
    The Global Fund's Sixth Replenishment Conference: a challenge for France, a challenge for global health.
    Lancet. 2019;394:1214-1215.
    PubMed    


    September 2019
  37. FOY BD, Rao S, Parikh S, Slater HC, et al
    Analysis of the RIMDAMAL trial - Authors' reply.
    Lancet. 2019;394:1006-1007.
    PubMed    


  38. COLEBUNDERS R, Kugler M, Fodjo JNS
    Analysis of the RIMDAMAL trial.
    Lancet. 2019;394:1006.
    PubMed    


  39. BRADLEY J, Moulton LH, Hayes R
    Analysis of the RIMDAMAL trial.
    Lancet. 2019;394:1005-1006.
    PubMed    


  40. GHEBREYESUS TA
    The malaria eradication challenge.
    Lancet. 2019 Sep 6. pii: S0140-6736(19)31951.
    PubMed    


  41. FEACHEM RGA, Chen I, Akbari O, Bertozzi-Villa A, et al
    Malaria eradication within a generation: ambitious, achievable, and necessary.
    Lancet. 2019 Sep 6. pii: S0140-6736(19)31139.
    PubMed    


  42. MSWATI IK 3RD
    An Africa free of malaria.
    Lancet. 2019 Sep 6. pii: S0140-6736(19)31952.
    PubMed    


    July 2019
  43. BATTLE KE, Lucas TCD, Nguyen M, Howes RE, et al
    Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000-17: a spatial and temporal modelling study.
    Lancet. 2019;394:332-343.
    PubMed     Abstract available


  44. ROSENTHAL PJ
    A shorter course for anti-relapse therapy against vivax malaria.
    Lancet. 2019 Jul 18. pii: S0140-6736(19)31605.
    PubMed    


  45. TAYLOR WRJ, Thriemer K, von Seidlein L, Yuentrakul P, et al
    Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial.
    Lancet. 2019 Jul 18. pii: S0140-6736(19)31285.
    PubMed     Abstract available


  46. SCHUERMAN L
    RTS,S malaria vaccine could provide major public health benefits.
    Lancet. 2019 Jul 9. pii: S0140-6736(19)31567.
    PubMed    


    June 2019
  47. NOSTEN FH, Phyo AP
    New malaria maps.
    Lancet. 2019 Jun 19. pii: S0140-6736(19)31273.
    PubMed    


  48. WEISS DJ, Lucas TCD, Nguyen M, Nandi AK, et al
    Mapping the global prevalence, incidence, and mortality of Plasmodium falciparum, 2000-17: a spatial and temporal modelling study.
    Lancet. 2019 Jun 19. pii: S0140-6736(19)31097.
    PubMed     Abstract available


    May 2019
  49. FRIEBEL R, Silverman R, Glassman A, Chalkidou K, et al
    On results reporting and evidentiary standards: spotlight on the Global Fund.
    Lancet. 2019;393:2006-2008.
    PubMed    


    April 2019
  50. ADEPOJU P
    RTS,S malaria vaccine pilots in three African countries.
    Lancet. 2019;393:1685.
    PubMed    


    March 2019
  51. LAUFER MK
    Beyond birthweight: benefits and risks of preventing malaria in pregnancy.
    Lancet. 2019 Mar 22. pii: S0140-6736(18)32615.
    PubMed    


  52. KAJUBI R, Ochieng T, Kakuru A, Jagannathan P, et al
    Monthly sulfadoxine-pyrimethamine versus dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial.
    Lancet. 2019 Mar 22. pii: S0140-6736(18)32224.
    PubMed     Abstract available


  53. CHACCOUR C, Rabinovich NR
    Advancing the repurposing of ivermectin for malaria.
    Lancet. 2019 Mar 13. pii: S0140-6736(18)32613.
    PubMed    


  54. FOY BD, Alout H, Seaman JA, Rao S, et al
    Efficacy and risk of harms of repeat ivermectin mass drug administrations for control of malaria (RIMDAMAL): a cluster-randomised trial.
    Lancet. 2019 Mar 13. pii: S0140-6736(18)32321.
    PubMed     Abstract available


  55. PAGE KR, Doocy S, Reyna Ganteaume F, Castro JS, et al
    Venezuela's public health crisis: a regional emergency.
    Lancet. 2019 Mar 11. pii: S0140-6736(19)30344.
    PubMed     Abstract available


    November 2018
  56. GHEBREYESUS TA, Admasu K
    Countries must steer new response to turn the malaria tide.
    Lancet. 2018;392:2246-2247.
    PubMed    


    August 2018
  57. TIONO AB, Ouedraogo A, Ouattara D, Bougouma EC, et al
    Efficacy of Olyset Duo, a bednet containing pyriproxyfen and permethrin, versus a permethrin-only net against clinical malaria in an area with highly pyrethroid-resistant vectors in rural Burkina Faso: a cluster-randomised controlled trial.
    Lancet. 2018 Aug 10. pii: S0140-6736(18)31711.
    PubMed     Abstract available


  58. GIMNIG JE, Ochomo E
    New opportunities for malaria vector control.
    Lancet. 2018 Aug 10. pii: S0140-6736(18)31817.
    PubMed    


    July 2018
  59. ZAROCOSTAS J
    African Union launches a pan-African anti-malaria campaign.
    Lancet. 2018;392:109.
    PubMed    


    June 2018
  60. PROTOPOPOFF N, Rowland M
    Accelerating the evidence for new classes of long-lasting insecticide-treated nets.
    Lancet. 2018;391:2415-2416.
    PubMed    


    April 2018
  61. COSTELLO A
    The Global Fund links with Lombard Odier bank.
    Lancet. 2018;391:1674-1675.
    PubMed    


  62. GHANI AC
    Can improving access to care help to eliminate malaria?
    Lancet. 2018 Apr 24. pii: S0140-6736(18)30910.
    PubMed    


  63. LANDIER J, Parker DM, Thu AM, Lwin KM, et al
    Effect of generalised access to early diagnosis and treatment and targeted mass drug administration on Plasmodium falciparum malaria in Eastern Myanmar: an observational study of a regional elimination programme.
    Lancet. 2018 Apr 24. pii: S0140-6736(18)30792.
    PubMed     Abstract available


  64. ZAROCOSTAS J
    Winnie Mpanju-Shumbusho: leader in the fight against malaria.
    Lancet. 2018;391:1566.
    PubMed    


  65. CHEN I, Cooney R, Feachem RGA, Lal A, et al
    The Lancet Commission on malaria eradication.
    Lancet. 2018 Apr 16. pii: S0140-6736(18)30911.
    PubMed    


  66. PROTOPOPOFF N, Mosha JF, Lukole E, Charlwood JD, et al
    Effectiveness of a long-lasting piperonyl butoxide-treated insecticidal net and indoor residual spray interventions, separately and together, against malaria transmitted by pyrethroid-resistant mosquitoes: a cluster, randomised controlled, two-by-two
    Lancet. 2018 Apr 11. pii: S0140-6736(18)30427.
    PubMed     Abstract available


  67. KILLEEN GF, Ranson H
    Insecticide-resistant malaria vectors must be tackled.
    Lancet. 2018 Apr 11. pii: S0140-6736(18)30844.
    PubMed    


  68. ASHLEY EA, Pyae Phyo A, Woodrow CJ
    Malaria.
    Lancet. 2018 Apr 6. pii: S0140-6736(18)30324.
    PubMed     Abstract available


    March 2018
  69. PARK KB, Khan U, Seung K
    Open letter to The Global Fund about its decision to end DPRK grants.
    Lancet. 2018;391:1257.
    PubMed    


  70. BASSAT Q, Krishna S
    Widening the options for recurrent malaria.
    Lancet. 2018 Mar 29. pii: S0140-6736(18)30630.
    PubMed    



  71. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    Lancet. 2018 Mar 29. pii: S0140-6736(18)30291.
    PubMed     Abstract available


  72. THE LANCET
    The Global Fund under Peter Sands.
    Lancet. 2018;391:912.
    PubMed    


    December 2017
  73. LIM R, Peto TJ, Tripura R, Cheah PY, et al
    Village Drama Against Malaria.
    Lancet. 2017;388:2990.
    PubMed    


    November 2017
  74. ALONSO P, Noor AM
    The global fight against malaria is at crossroads.
    Lancet. 2017 Nov 28. pii: S0140-6736(17)33080.
    PubMed    


    May 2017
  75. THE LANCET
    The next chapter in malaria eradication.
    Lancet. 2017;389:1772.
    PubMed    


    February 2017
  76. GAN P
    Picturing health: making malaria visible in Asia-Pacific.
    Lancet. 2017;389:789-798.
    PubMed    


  77. BAIRD JK
    Telling the human story of Asia's invisible malaria burden.
    Lancet. 2017;389:781-782.
    PubMed    


    January 2017
  78. CLINTON C, Sridhar D
    Who pays for cooperation in global health? A comparative analysis of WHO, the World Bank, the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria, and Gavi, the Vaccine Alliance.
    Lancet. 2017 Jan 27. pii: S0140-6736(16)32402.
    PubMed     Abstract available


    October 2016

  79. Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    Lancet. 2016;388:1725-1774.
    PubMed     Abstract available


  80. LU GY, Liu YB, Beiersmann C, Feng Y, et al
    Operational challenges to the 1-3-7 surveillance strategy for malaria elimination in China: a qualitative study.
    Lancet. 2016;388 Suppl 1:S15.
    PubMed     Abstract available


    September 2016
  81. WATTS G
    Harrison Clark Spencer.
    Lancet. 2016;388:1154.
    PubMed    


  82. SENARATNE R, Singh PK
    Against the odds, Sri Lanka eliminates malaria.
    Lancet. 2016;388:1038-9.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Malaria is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: